FDA Approves Lonsurf Plus Avastin for Metastatic Colorectal Cancer 🔗 Access full article via CureToday FDA approves combination of Lonsurf and Avastin for patients with metastatic colorectal cancer . Patients previously treated with chemotherapies, an anti-VEGF Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon